Salivary immunoglobulins in progressive systemic sclerosis

Area of Science:

• Immunology
• Rheumatology
• Gastroenterology

Background:

• Progressive systemic sclerosis (PSS) is an autoimmune disease affecting connective tissues.
• Salivary gland dysfunction is a common manifestation in autoimmune disorders.
• Immunoglobulin analysis in saliva offers insights into local immune responses.

Purpose of the Study:

• To investigate the presence and significance of salivary immunoglobulins, particularly IgM, in patients with progressive systemic sclerosis.
• To correlate salivary immunoglobulin levels with labial minor salivary gland immunocyte populations.
• To explore the diagnostic potential of salivary IgM for Sjögren's syndrome.

Main Methods:

• Saliva samples were analyzed for immunoglobulin (IgM, IgA, IgG) concentrations.
• Labial biopsies were examined using immunofluorescence to assess immunocyte populations.
• Correlations between salivary and serum immunoglobulin levels were assessed.

Main Results:

• Salivary IgM was present in 11 out of 17 PSS patients, often with increased IgA and IgG.
• Immunofluorescence revealed increased IgM, IgA, and IgG cells in labial minor salivary glands.
• Patients with nodular lymphoplasmacyte infiltration of salivary glands consistently showed salivary IgM.
• No correlation was found between salivary and serum immunoglobulin concentrations.
• A correlation existed between salivary IgM concentration and the number of IgM immunocytes.

Conclusions:

• The presence of salivary IgM in PSS patients is linked to local glandular synthesis, not serum levels.
• Salivary IgM may serve as a diagnostic criterion for Sjögren's syndrome.
• Immunoglobulin analysis in saliva provides valuable information on autoimmune-related glandular pathology.